Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma.
Xu MH, Zheng YM, Liang BG, Xu WX, Cao J, Wang P, Dong ZY, Zhou CH, Sun HC, Ren N, et al. Int J Biol Sci. 2024; 20(9):3269-3284. Epub 2024 Jun 3.